Methods of treating or preventing a cardiovascular system complication of sickle cell disease with an anti-G-CSFR antibody
US12357689B2 · kind B2 · utility
0Cited by
22References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2024 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | Oct 8, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods for treating or preventing or delaying progression or reducing or inhibiting or hindering development of a complication associated with sickle cell disease in a subject suffering from sickle cell disease, the method comprising administering to the subject a compound that inhibits granulocyte colony stimulating factor (G-CSF) signaling and/or G-CSF activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.